TY - JOUR T1 - Modelling the impact of household size distribution on the transmission dynamics of COVID-19 JF - medRxiv DO - 10.1101/2021.01.12.21249707 SP - 2021.01.12.21249707 AU - Pengyu Liu AU - Lisa McQuarrie AU - Yexuan Song AU - Caroline Colijn Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/01/13/2021.01.12.21249707.abstract N2 - Under the implementation of non-pharmaceutical interventions such as social distancing and lockdowns, household transmission has been shown to be significant for COVID-19, posing challenges for reducing incidence in settings where people are asked to self-isolate at home and to spend increasing amounts of time at home due to distancing measures. Accordingly, characteristics of households in a region have been shown to relate to transmission heterogeneity of the virus. We introduce a stochastic epidemiological model to examine the impact of the household size distribution in a region on the transmission dynamics. We choose parameters to reflect incidence in two health regions of the Greater Vancouver area in British Columbia and simulate the impact of distancing measures on transmission, with household size distribution the only different parameter between simulations for the two regions. Our result suggests that the dissimilarity in household size distribution alone can cause significant differences in incidence of the two regions, and the distributions drive distinct dynamics that match reported cases. Furthermore, our model suggests that offering individuals a place to isolate outside their household can speed the decline in cases, and does so more effectively where there are more larger households.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the grant of the Federal Government of Canada 150 Research Chair program to Prof. C. Colijn and by Genome BC grant COV142.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesHousehold data from Statistic Canada 2016 Census are available at Statistics Canada website. COVID-19 case data in British Columbia are available at BCCDC website. https://www12.statcan.gc.ca/census-recensement/2016/dp-pd/index-eng.cfm http://www.bccdc.ca/health-info/diseases-conditions/covid-19/data ER -